BALLARD PARTNERS

Lobbying for GENETIX BIOTHERAPEUTICS INC. · Biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $120,000.00 income · posted Jul 15, 2026

Lobbying activity 1

Health Issues

Advocacy regarding an FDA issue.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem